Most dysregulated miRNAs are associated with molecular mechanisms occurring during AD pathogenesis, such as inflammation, apoptosis, Aβ and tau signaling pathways [88], suggesting them as an alternative and more sensitive approach for detection and management of AD [89]. The gene discussed is MAPT; the disease is Alzheimer disease.